tiprankstipranks
Trending News
More News >
Firebrick Pharma Limited (AU:FRE)
ASX:FRE
Australian Market

Firebrick Pharma Limited (FRE) Technical Analysis

Compare
7 Followers

Summary of all the Indicators

Overall Consensus
Sell
7Bullish
2Neutral
13Bearish
Technical Analysis Consensus
Buy
7Bullish
1Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
1Neutral
11Bearish
Firebrick Pharma Limited’s (FRE) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Firebrick Pharma Limited is a Buy.
Firebrick Pharma Limited’s (FRE) 20-Day exponential moving average is 0.05, while Firebrick Pharma Limited’s (FRE) share price is <AU$0.1, making it a Sell.
Firebrick Pharma Limited’s (FRE) 50-Day exponential moving average is 0.06, while Firebrick Pharma Limited’s (FRE) share price is <AU$0.1, making it a Sell.

Firebrick Pharma Limited (FRE) Pivot Points

Dec 18, 2025, 07:25 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.05
0.05
0.05
0.05
0.05
0.05
0.05
Fibonacci
0.05
0.05
0.05
0.05
0.05
0.05
0.05
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Firebrick Pharma Limited (FRE) Moving Averages

Dec 18, 2025, 07:25 PM
Period
Simple
Exponential
MA5
0.05Neutral
0.05Sell
MA10
0.05Sell
0.05Sell
MA20
0.06Sell
0.05Sell
MA50
0.06Sell
0.06Sell
MA100
0.07Sell
0.06Sell
MA200
0.07Sell
0.07Sell
Firebrick Pharma Limited’s (FRE) 10-Day exponential moving average is 0.05, while Firebrick Pharma Limited’s (FRE) share price is <AU$0.1, making it a Sell.
Firebrick Pharma Limited’s (FRE) 100-Day exponential moving average is 0.06, while Firebrick Pharma Limited’s (FRE) share price is <AU$0.1, making it a Sell.
Firebrick Pharma Limited’s (FRE) stock price is <AU$0.1 and Firebrick Pharma Limited’s (FRE) 50-day simple moving average is 0.06, creating a Sell signal.
Firebrick Pharma Limited’s (FRE) stock price is <AU$0.1 and Firebrick Pharma Limited’s (FRE) 100-day simple moving average is 0.07, creating a Sell signal.
Firebrick Pharma Limited’s (FRE) stock price is <AU$0.1 and Firebrick Pharma Limited’s (FRE) 200-day simple moving average is 0.07, creating a Sell signal.

Firebrick Pharma Limited (FRE) Technical Indicators

Dec 18, 2025, 07:25 PM
Name
Value
Implied Action
RSI (14)
17.24
Buy
STOCH (9,6)
-7.14
Buy
STOCHRSI (14)
-7.14
Buy
MACD (12,26)
>-0.01
Buy
ADX (14)
12.61
Buy
Williams %R
-107.14
Buy
CCI (14)
-82.07
Neutral
ATR (14)
<0.01
-
Ultimate Oscillator
6.18
Sell
ROC
-16.67
Sell
Firebrick Pharma Limited’s (FRE) Relative Strength Index (RSI) is 17.24, creating a Buy signal.
Firebrick Pharma Limited’s (FRE) Trend Strength Indicator (ADX) is 12.61, creating a Buy signal.
Firebrick Pharma Limited’s (FRE) Commodity Channel Index (CCI) is -82.07, creating a Neutral signal.
Firebrick Pharma Limited’s (FRE) Price Rate of Change (ROC) is -16.67, creating a Sell signal.

FAQ

Is FRE a Buy, Hold, or Sell?
Based on FRE’s technical indicators, FRE is a Sell.
    What is FRE’s RSI (14)?
    FRE’s RSI (14) is 17.24, which suggests FRE is a Buy.
      What is FRE’s MACD?
      FRE’s MACD is >-0.01, which suggests FRE is a Buy.
        What is FRE’s 5-day moving average?
        FRE’s 5-day moving average is 0.05, which suggests FRE is a Neutral.
          What is FRE’s 20-day moving average?
          FRE 20-day moving average is 0.06, which suggests FRE is a Sell.
            What is FRE’s 50-day moving average?
            FRE’s 50-day moving average is 0.06, which suggests FRE is a Sell.
              What is FRE’s 200-day moving average?
              FRE’s 200-day moving average is 0.07, which suggests FRE is a Sell.
                What is FRE’s Williams % R (14)?
                FRE’s Williams % R (14) is -107.14, which suggests FRE is a Buy.
                  What is FRE’s CCI (14)?
                  FRE’s CCI (14) is -82.07, which suggests FRE is a Neutral.
                    What is the share price of Firebrick Pharma Limited?